These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12412173

  • 1. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, Kohno H, Nagasue N.
    Cancer; 2002 Nov 15; 95(10):2188-95. PubMed ID: 12412173
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
    Miyashita M, Tajiri T, Yanagi K, Shimizu T, Futami R, Sasajima K, Tokunaga A.
    Hepatogastroenterology; 2003 Nov 15; 50(50):308-9. PubMed ID: 12749209
    [Abstract] [Full Text] [Related]

  • 3. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR, Libutti SK.
    Clin Cancer Res; 2000 Dec 15; 6(12):4628-34. PubMed ID: 11156212
    [Abstract] [Full Text] [Related]

  • 4. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST.
    Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Apr 15; 20(4):583-8. PubMed ID: 15836707
    [Abstract] [Full Text] [Related]

  • 7. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
    Feldman AL, Alexander HR, Yang JC, Linehan WM, Eyler RA, Miller MS, Steinberg SM, Libutti SK.
    Cancer; 2002 Oct 15; 95(8):1637-43. PubMed ID: 12365010
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
    Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M.
    Hepatology; 1996 Mar 15; 23(3):455-64. PubMed ID: 8617424
    [Abstract] [Full Text] [Related]

  • 10. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T, Aoyagi M, Tamaki M, Yoshino Y, Hori H, Duan L, Yano T, Shibata M, Ohno K, Hirakawa K, Yamaguchi N.
    Clin Cancer Res; 2002 Sep 15; 8(9):2933-8. PubMed ID: 12231538
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.
    Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST.
    Br J Surg; 2004 Oct 15; 91(10):1354-60. PubMed ID: 15376182
    [Abstract] [Full Text] [Related]

  • 12. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 13. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar 01; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H.
    Hepatology; 2002 Apr 01; 35(4):834-42. PubMed ID: 11915029
    [Abstract] [Full Text] [Related]

  • 15. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Lupus; 2002 Apr 01; 11(6):348-55. PubMed ID: 12139372
    [Abstract] [Full Text] [Related]

  • 16. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
    Li XM, Tang ZY, Qin LX, Zhou J, Sun HC.
    J Exp Clin Cancer Res; 1999 Dec 01; 18(4):511-7. PubMed ID: 10746978
    [Abstract] [Full Text] [Related]

  • 17. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM.
    J Cell Biochem; 2003 May 01; 89(1):133-43. PubMed ID: 12682914
    [Abstract] [Full Text] [Related]

  • 18. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J, Hu J, Cai J.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 01; 23(5):389-92. PubMed ID: 11810769
    [Abstract] [Full Text] [Related]

  • 19. A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma.
    Iguchi H, Yokota M, Fukutomi M, Uchimura K, Yonemasu H, Hachitanda Y, Nakao Y, Tanaka Y, Sumii T, Funakoshi A.
    J Exp Clin Cancer Res; 2002 Sep 01; 21(3):309-13. PubMed ID: 12385570
    [Abstract] [Full Text] [Related]

  • 20. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI, Chow NH, Lai KH, Yang HB, Chan SH, Lin XZ, Cheng JS, Huang JS, Ger LP, Huang SM, Yen MY, Yang YF.
    Anticancer Res; 1997 Sep 01; 17(4A):2803-9. PubMed ID: 9252719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.